Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Prolaio
AddedFeb 17, 2024
UpdatedJun 18, 2026
Prolaio

Prolaio

Scottsdale-based Prolaio is a HealthTech software company specializing in prescriptive analytics.

HQ
Scottsdale, AZ, US
Overview
Compare
Fundraising
Employees
Website

Founded in Scottsdale, Arizona, Prolaio is a HealthTech software company specializing in prescriptive analytics. Their core mission is to leverage data to connect care teams, patients, and researchers to improve outcomes for individuals with heart conditions. Prolaio offers advanced analytics solutions that aim to address the significant challenges posed by heart disease, which remains the leading cause of death in the United States.

Prolaio has garnered attention for its innovative approach to healthcare analytics, though specific notable affiliated people and investors are not mentioned. The company has made significant strides in the HealthTech sector by focusing on a critical area of need—cardiovascular health. Their impact is underscored by their commitment to reducing the high mortality and financial costs associated with heart disease through data-driven solutions.

Prolaio - Similar Companies

HealthReveal logo

HealthReveal

HealthOpX logo

HealthOpX

healthopx.com

PMI logo

PMI

CardioPhi logo

CardioPhi

Precise.ly logo

Precise.ly

HealthPals logo

HealthPals

PulseData logo

PulseData

pulsedata.io

PriorAuthNow logo

PriorAuthNow

Limmi logo

Limmi

limmi.io

Prognos Health logo

Prognos Health

prognoshealth.com

Vital Labs logo

Vital Labs

vitallabs.co

ModoScript logo

ModoScript

modoscript.com

Moving Analytics logo

Moving Analytics

kelaHealth logo

kelaHealth

kelahealth.com

Prolung logo

Prolung

Prolaio - Quick Facts

Who are Prolaio's competitors?

Companies similar to Prolaio include HealthReveal, HealthOpX, PMI and CardioPhi.

Where is Prolaio's headquarters located?

Prolaio's headquarters is located in Scottsdale, AZ, US.

When was Prolaio's last funding round?

Prolaio's most recent funding round was for $25.5M (USD) in July 2023.

How much has Prolaio raised to-date?

As of Jul 26, 2023, Prolaio has raised a total of $25.5M (USD).

How many employees does Prolaio have?

Prolaio has 50 employees as of Feb 5, 2024.

Prolaio - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Analytics Software
Tags
  • Data
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software